AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Famprofazone provides relief from mild to moderate pain by inhibiting the synthesis of prostaglandins, which are chemicals involved in the inflammatory response. By reducing prostaglandin levels, famprofazone helps alleviate pain associated with various conditions.
Anti-inflammatory Effects: Like other NSAIDs, famprofazone possesses anti-inflammatory properties, which can help reduce inflammation, swelling, and redness in affected tissues. This makes it useful in managing inflammatory conditions such as arthritis and tendonitis.
Antipyretic Effects: Famprofazone also has antipyretic properties, meaning it can help reduce fever by acting on the hypothalamus, the part of the brain that regulates body temperature. It is sometimes used to alleviate fever associated with infections or inflammatory conditions.
Musculoskeletal Conditions: Famprofazone was primarily indicated for the treatment of musculoskeletal conditions characterized by pain and inflammation, including rheumatoid arthritis, osteoarthritis, gout, and soft tissue injuries.
Gastrointestinal Effects: Like other NSAIDs, famprofazone can irritate the gastrointestinal (GI) tract and increase the risk of GI complications such as ulcers, bleeding, and perforation. Long-term use or high doses of famprofazone may exacerbate these risks.
Cardiovascular Effects: NSAIDs, including famprofazone, have been associated with an increased risk of cardiovascular events such as heart attack and stroke, particularly when used at high doses or for long durations. Individuals with existing cardiovascular risk factors may be at higher risk.
Renal Effects: NSAIDs can cause kidney-related side effects such as fluid retention, decreased kidney function, and in rare cases, acute kidney injury or kidney failure. Patients with pre-existing kidney conditions or those taking other medications that affect kidney function may be at increased risk.
Hepatic Effects: Some NSAIDs, including famprofazone, have been associated with liver toxicity and abnormal liver function tests. Patients with liver disease or those taking other medications that affect liver function should use famprofazone with caution.
Hematologic Effects: NSAIDs can interfere with platelet function and increase the risk of bleeding, particularly when used in combination with anticoagulant medications. Patients on anticoagulant therapy or those with bleeding disorders should use famprofazone with caution.
Allergic Reactions: Like all medications, famprofazone can cause allergic reactions in some individuals. Symptoms of an allergic reaction may include rash, itching, swelling, dizziness, difficulty breathing, or swelling of the face, lips, tongue, or throat. If any of these symptoms occur, medical attention should be sought immediately.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 2 | Bacteroides | genus | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
2 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Bacteroides uniformis ATCC 8492 | strain | Increases |
0 | 1 | Bacteroides uniformis CL03T00C23 | strain | Increases |
0 | 1 | Bacteroides uniformis dnLKV2 | strain | Increases |
0 | 1 | Bacteroides uniformis str. 3978 T3 i | strain | Increases |
0 | 1 | Bacteroides uniformis str. 3978 T3 ii | strain | Increases |
0 | 1 | Bacteroides uniformis CL03T12C37 | strain | Increases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | |
Acne | 0.3 | 0.7 | -1.33 |
ADHD | 3.9 | 0.9 | 3.33 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.4 | 0.25 |
Allergic Rhinitis (Hay Fever) | 1.8 | 2 | -0.11 |
Allergies | 3.6 | 2.5 | 0.44 |
Allergy to milk products | 1 | 1.3 | -0.3 |
Alopecia (Hair Loss) | 0.6 | 0.6 | |
Alzheimer's disease | 4.2 | 5.1 | -0.21 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.2 | 0.5 | 3.4 |
Ankylosing spondylitis | 2.5 | 0.9 | 1.78 |
Anorexia Nervosa | 1.5 | 2.6 | -0.73 |
Antiphospholipid syndrome (APS) | 1.1 | 1.1 | |
Asthma | 4.4 | 2.1 | 1.1 |
Atherosclerosis | 1.6 | 1.6 | 0 |
Atrial fibrillation | 2.8 | 1.3 | 1.15 |
Autism | 6.7 | 6.8 | -0.01 |
Autoimmune Disease | 1.2 | 1 | 0.2 |
Barrett esophagus cancer | 0.6 | 0.3 | 1 |
benign prostatic hyperplasia | 0.6 | 0.6 | |
Biofilm | 1.5 | 1.5 | |
Bipolar Disorder | 1.8 | 1.7 | 0.06 |
Brain Trauma | 0.6 | 1.1 | -0.83 |
Breast Cancer | 0.8 | 0.3 | 1.67 |
Cancer (General) | 0.9 | 2.2 | -1.44 |
Carcinoma | 2.9 | 1.3 | 1.23 |
Celiac Disease | 2.3 | 2 | 0.15 |
Cerebral Palsy | 1.1 | 0.8 | 0.38 |
Chronic Fatigue Syndrome | 3.8 | 3.4 | 0.12 |
Chronic Kidney Disease | 2.6 | 1.6 | 0.63 |
Chronic Lyme | 0.1 | 0.5 | -4 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.4 | 2 | 0.2 |
Chronic Urticaria (Hives) | 1.5 | 0.7 | 1.14 |
Coagulation / Micro clot triggering bacteria | 1.4 | 1.1 | 0.27 |
Cognitive Function | 1.9 | 1.6 | 0.19 |
Colorectal Cancer | 7.9 | 1.4 | 4.64 |
Constipation | 1.7 | 0.5 | 2.4 |
Coronary artery disease | 1.3 | 2 | -0.54 |
COVID-19 | 6.9 | 6.4 | 0.08 |
Crohn's Disease | 6.3 | 3.5 | 0.8 |
Cushing's Syndrome (hypercortisolism) | 0.6 | -0.6 | |
cystic fibrosis | 0.7 | 1.4 | -1 |
d-lactic acidosis (one form of brain fog) | 0.1 | 0.1 | |
deep vein thrombosis | 2.7 | 1.1 | 1.45 |
Denture Wearers Oral Shifts | 1.1 | 1.1 | |
Depression | 9.4 | 5.6 | 0.68 |
Dermatomyositis | 0.3 | 0.3 | 0 |
Eczema | 1.7 | 2.6 | -0.53 |
Endometriosis | 2 | 2.1 | -0.05 |
Eosinophilic Esophagitis | 0.3 | 0.6 | -1 |
Epilepsy | 2.4 | 1.4 | 0.71 |
erectile dysfunction | 1.1 | 0.3 | 2.67 |
Fibromyalgia | 2.4 | 0.6 | 3 |
Functional constipation / chronic idiopathic constipation | 4.9 | 3.6 | 0.36 |
gallstone disease (gsd) | 2.6 | 1.2 | 1.17 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.9 | 0.6 | 2.17 |
Generalized anxiety disorder | 1.9 | 1.7 | 0.12 |
giant cell arteritis | 0.2 | -0.2 | |
Glioblastoma | 0.3 | -0.3 | |
Gout | 1.1 | 0.8 | 0.38 |
Graves' disease | 1.3 | 2 | -0.54 |
Gulf War Syndrome | 0.8 | 1.7 | -1.13 |
Halitosis | 1 | 0.3 | 2.33 |
Hashimoto's thyroiditis | 2.8 | 1 | 1.8 |
Heart Failure | 2.5 | 1.2 | 1.08 |
hemorrhagic stroke | 0.7 | 0.7 | |
Hidradenitis Suppurativa | 0.9 | 0.3 | 2 |
High Histamine/low DAO | 1.1 | 0.6 | 0.83 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.1 | 5 |
hyperglycemia | 1.9 | 0.8 | 1.37 |
Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
hypertension (High Blood Pressure | 3.3 | 4 | -0.21 |
Hypothyroidism | 0 | 0.9 | 0 |
Hypoxia | 1.9 | 0.3 | 5.33 |
IgA nephropathy (IgAN) | 1.6 | 2.6 | -0.63 |
Inflammatory Bowel Disease | 6.7 | 6 | 0.12 |
Insomnia | 1.4 | 1.8 | -0.29 |
Intelligence | 0.7 | 0.7 | |
Intracranial aneurysms | 1 | 0.6 | 0.67 |
Irritable Bowel Syndrome | 5.1 | 4.1 | 0.24 |
ischemic stroke | 1.8 | 1.1 | 0.64 |
Liver Cirrhosis | 5.6 | 3.3 | 0.7 |
Long COVID | 4.8 | 4.7 | 0.02 |
Low bone mineral density | 1.1 | -1.1 | |
Lung Cancer | 1.1 | 0.4 | 1.75 |
Lymphoma | 0.6 | 0.6 | |
Mast Cell Issues / mastitis | 1.1 | 0.9 | 0.22 |
ME/CFS with IBS | 0.5 | 0.4 | 0.25 |
ME/CFS without IBS | 1.3 | 0.9 | 0.44 |
membranous nephropathy | 0.3 | 0.3 | |
Menopause | 1.4 | 0.6 | 1.33 |
Metabolic Syndrome | 5.1 | 5.7 | -0.12 |
Mood Disorders | 9.2 | 5.1 | 0.8 |
multiple chemical sensitivity [MCS] | 1.2 | 1.2 | |
Multiple Sclerosis | 5.3 | 3.8 | 0.39 |
Multiple system atrophy (MSA) | 0.8 | 0.6 | 0.33 |
myasthenia gravis | 0.9 | 0.7 | 0.29 |
neuropathic pain | 0.3 | 1.9 | -5.33 |
Neuropathy (all types) | 0.6 | 1.7 | -1.83 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.3 | 2.8 | 0.18 |
NonCeliac Gluten Sensitivity | 0.7 | 0.3 | 1.33 |
Obesity | 6.7 | 7.2 | -0.07 |
obsessive-compulsive disorder | 4.5 | 1.7 | 1.65 |
Osteoarthritis | 1.2 | 0.9 | 0.33 |
Osteoporosis | 2.2 | 0.4 | 4.5 |
pancreatic cancer | 0.7 | 0.3 | 1.33 |
Parkinson's Disease | 6.4 | 4.7 | 0.36 |
Polycystic ovary syndrome | 6.3 | 2.6 | 1.42 |
Postural orthostatic tachycardia syndrome | 0.2 | 0.6 | -2 |
Premenstrual dysphoric disorder | 0.3 | 0.4 | -0.33 |
primary biliary cholangitis | 0.6 | 0.9 | -0.5 |
Primary sclerosing cholangitis | 2.2 | 1.9 | 0.16 |
Psoriasis | 2.1 | 1.9 | 0.11 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.3 | 2.8 | 0.54 |
Rosacea | 1 | 1 | 0 |
Schizophrenia | 4.3 | 2.7 | 0.59 |
scoliosis | 0.4 | 0.3 | 0.33 |
Sjögren syndrome | 2 | 1.4 | 0.43 |
Sleep Apnea | 1.5 | 1.4 | 0.07 |
Slow gastric motility / Gastroparesis | 0.7 | 0.3 | 1.33 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.4 | 0.1 | 13 |
Stress / posttraumatic stress disorder | 1.9 | 2.2 | -0.16 |
Systemic Lupus Erythematosus | 3.6 | 2.3 | 0.57 |
Tic Disorder | 1.4 | 0.3 | 3.67 |
Tourette syndrome | 0.3 | 0.3 | |
Type 1 Diabetes | 3.7 | 3.5 | 0.06 |
Type 2 Diabetes | 5.7 | 6 | -0.05 |
Ulcerative colitis | 4.1 | 5 | -0.22 |
Unhealthy Ageing | 3.3 | 1.9 | 0.74 |
Vitiligo | 2.2 | 1 | 1.2 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]